Rigel Pharmaceuticals (RIGL) FCF Margin (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,687.00 |
| Dec 31, 2025 | -309.00 |
| Sep 30, 2025 | 456.00 |
| Jun 30, 2025 | 3,171.00 |
| Mar 31, 2025 | -2,681.00 |
| Dec 31, 2024 | -1,406.00 |
| Sep 30, 2024 | 3,838.00 |
| Jun 30, 2024 | 1,779.00 |
| Mar 31, 2024 | 46.00 |
| Dec 31, 2023 | -1,260.00 |
| Sep 30, 2023 | -2,689.00 |
| Jun 30, 2023 | 3,768.00 |
| Mar 31, 2023 | 2,724.00 |
| Dec 31, 2022 | 1,733.00 |
| Sep 30, 2022 | -1,702.00 |
| Jun 30, 2022 | 11,136.00 |
| Mar 31, 2022 | -6,112.00 |
| Dec 31, 2021 | -4,483.00 |
| Sep 30, 2021 | -25,726.00 |
| Jun 30, 2021 | 23,339.00 |
| Mar 31, 2021 | 6,241.00 |
| Dec 31, 2020 | 1,987.00 |
| Sep 30, 2020 | -1,966.00 |
| Jun 30, 2020 | -8,071.00 |
| Mar 31, 2020 | 5,999.00 |
| Dec 31, 2019 | 526.00 |
| Sep 30, 2019 | 8,922.00 |
| Jun 30, 2019 | -15,361.00 |
| Mar 31, 2019 | -3,807.00 |
| Dec 31, 2018 | 44,657.00 |
| Sep 30, 2018 | 113,286.00 |
| Dec 31, 2017 | 240,375.00 |
| Mar 31, 2017 | -16,477.00 |
| Dec 31, 2016 | 19,133.00 |
| Sep 30, 2016 | -38,988.00 |
| Jun 30, 2016 | 23,508.00 |
| Mar 31, 2016 | -28,901.00 |
| Dec 31, 2015 | -8,805.00 |
| Sep 30, 2015 | 27,632.00 |
| Jun 30, 2015 | -117,583.00 |
| Jun 30, 2012 | 187,573.00 |
| Sep 30, 2011 | 421,539.00 |